Clinical Trials Logo

24-week PCR Negativity of Telbivudine clinical trials

View clinical trials related to 24-week PCR Negativity of Telbivudine.

Filter by:
  • None
  • Page 1

NCT ID: NCT01958229 Completed - Chronic Hepatitis B Clinical Trials

Efficacy Study of Telbivudine in Chronic Hepatitis B Patients

Start date: December 2009
Phase: N/A
Study type: Observational

This study is designed to support the optimal use of telbivudine by providing data to refine our understanding of telbivudine efficacy and resistance in real life clinical setting in patients with chronic hepatitis B with defined baseline characteristics and 24-week PCR negativity.